Catheter Stabilization Devices Market Size Analysis:

Catheter Stabilization Devices Market Size was valued at USD 1.48 Billion in 2023 and is expected to reach USD 2.77 billion by 2032, growing at a CAGR of 7.22% over the forecast period 2024-2032.

This report provides key statistical insights and emerging trends shaping the Catheter Stabilization Devices Market. It emphasizes on increasing incidence of catheterization and complications associated with it, which would generate demand for securement devices. Increased acceptance in North America and Europe means regional prescription trends will show higher adoption because of stricter infection control protocols. Reporting on device volume growth, it shows a continued increase in demand globally. It also analyzes expenditure patterns across public, private, and out-of-pocket segments. It also highlights stabilization device importance in minimizing the risk of hospital-acquired infections and assesses the regulatory landscape in prominent geographies. These insights collectively reflect the market’s evolving landscape, technological adoption, and growing importance of patient safety and care efficiency.

The increasing incidence of chronic disease conditions such as cardiovascular diseases, cancer, and neurological disorders, which require catheter placement for treatment, is driving the growth of the catheter stabilization devices market. The catheter stabilization devices market in the USA has observed steady year-on-year growth, increasing from USD 0.40 billion to USD 0.74 billion in a decade. This reflects a compound annual growth rate (CAGR) of 7.12%, driven by increasing hospital admissions, stringent safety protocols, and a strong focus on reducing catheter-related complications. The surge indicates strong demand backed by public and private healthcare spending in India. For example, the Centers for Disease Control and Prevention (CDC) states that, in the United States, more than 300 million catheters are used each year, of which almost 3 million are central venous catheters.

Catheter Stabilization Devices Market Dynamics

Drivers

• The increasing prevalence of chronic diseases, such as cardiovascular conditions and cancer, necessitates catheterization procedures, thereby boosting the demand for catheter stabilization devices. ​

The growing prevalence of chronic diseases across the globe is a key factor propelling the growth of the catheter stabilization devices market. Cardiovascular diseases (CVDs) are the leading cause of death worldwide, with ischemic heart disease accounting for approximately 9.1 million deaths 13% of total deaths that occurred in 2021. As of 2021, approximately 6.9% of the adult population in OECD countries suffer from diabetes, and the condition can give rise to several complications, which frequent catheterization procedures can help address. Chronic obstructive pulmonary disease (COPD) is another major global health burden, affecting about 213 million people or 2.7% of the population worldwide, and contributing to 3.65 million deaths in 2021. The growing prevalence of these chronic diseases has led to an increase in the number of patients undergoing medical procedures that require the use of catheters, including intravenous therapies, dialysis, and cardiac interventions. As a result, the need for catheter stabilization devices has increased, as these devices play a critical role in securing catheters, reducing complications such as dislodgement or infection, and promoting effective treatment administration. This trend underscores the critical role of catheter stabilization devices in managing the healthcare needs of a population increasingly affected by chronic diseases.​

Restraint

• The availability of alternative products, like dressing tapes, presents cost-effective options that may limit the adoption of specialized catheter stabilization devices. ​

​The catheter stabilization devices market faces notable challenges due to the availability of alternative securement methods, particularly adhesive dressings and tapes. These alternatives are often perceived as more cost-effective, leading healthcare providers to favor them over specialized stabilization devices. This preference is especially pronounced in regions with constrained healthcare budgets, where cost considerations heavily influence procurement decisions. While adhesive dressings and tapes may offer initial cost savings, they can be associated with higher rates of catheter-related complications, such as dislodgement and infection. For instance, a study comparing various securement methods found that certain investigational devices displayed higher mean peak axial pull forces (40–41 N) compared to sutures (28 N) and securement dressings (17 N), indicating superior catheter stabilization. Despite the clinical advantages of specialized stabilization devices, their higher upfront costs can deter widespread adoption, particularly in cost-sensitive healthcare settings. This economic restraint underscores the need for comprehensive cost-benefit analyses to demonstrate the long-term value of catheter stabilization devices in reducing complications and associated healthcare costs.

Opportunity

• The rising trend of home-based healthcare and remote patient monitoring opens avenues for catheter stabilization devices designed specifically for homecare settings. ​

​The global shift towards home-based healthcare and remote patient monitoring is significantly influencing the demand for catheter stabilization devices tailored for home settings. As healthcare systems aim to reduce hospital stays and manage chronic conditions more effectively, the emphasis on home care has intensified. For instance, in the United States, approximately 3 million central venous catheters are utilized annually, underscoring the widespread need for effective catheter management across various settings, including homes. Similarly, the Asia-Pacific region is experiencing rapid growth in the catheter stabilization market, driven by increasing healthcare expenditure and a rising prevalence of chronic diseases. These trends highlight the growing necessity for catheter stabilization devices that are user-friendly and safe for home use, enabling patients to manage their conditions effectively outside traditional healthcare facilities. Manufacturers are thus presented with the opportunity to innovate and develop products that cater specifically to the home healthcare market, addressing both patient comfort and safety.

Challenge

• Navigating stringent regulatory requirements for medical devices can pose challenges for market entry and product commercialization, especially for small and medium-sized manufacturers.

The regulatory landscape is complex for manufacturers of catheter stabilization devices. Furthermore, the lack of shared regulations around the globe means companies have to adapt their compliance to different and changing standards, resulting in greater complication and resource allocation. According to a 2024 recent survey in Europe, more than 50% of the time an organization spends on the conformity assessment is used up in pre-review and certificate issuing processes rather than the review phase itself, revealing inefficiencies in the regulatory framework. In addition, the EU MDR has introduced significant compliance costs and timelines for medical device certifications, with an average processing time of 18 months. Moreover, the combined effect of these points affects the financial and operational resources, especially for the small and medium enterprises (SMEs), leading to an innovation bottleneck and time-to-market delays in the catheter stabilization technologies. While it is important to recognize the challenges, efforts like the International Medical Device Regulators Forum (IMDRF) are driving convergence through programs such as the Medical Device Single Audit Program (MDSAP), where a single audit may be recognized by multiple regulators. However, despite these efforts, achieving global harmonization remains a complex and gradual process, requiring ongoing collaboration among international regulatory bodies to streamline compliance pathways and facilitate market access for medical device manufacturers.

Catheter Stabilization Devices Market Segment Analysis

By Product

The arterial securement devices segment accounted for the largest share of the market in 2023 due to the crucial nature of their application in cardiovascular procedures. Factors like the increasing incidence of cardiovascular diseases worldwide contribute to a rise in arterial catheterizations. As still a leading cause of morbidity globally, they require advanced medical interventions, according to government data. These devices ensure secure placement during arterial catheterization, reducing risks such as dislodgement or infection. This segment has also been further bolstered by technological advancements. For instance, adapters have been created with improved adhesive strength and antimicrobial distractions in manufacturing for arterial securement to reduce complications. In addition, increased utilization of arterial catheters in minimally invasive surgeries has led to an increase in the uptake of these devices.  In North America alone, arterial securement devices accounted for substantial revenue due to high procedural volumes and advanced healthcare systems. Emerging markets are also contributing to this segment's growth. There is a rapid increase in cardiovascular interventions in the Asia-Pacific due to lifestyle-related diseases as well as developing healthcare infrastructure. An increase in geographically rooted government initiatives aimed at ensuring access to healthcare and educating people about infection prevention has also been contributing to the wide demand for arterial securement devices across the world.

By End Use

In 2023, hospitals accounted for the largest share of the catheter stabilization devices market at 58%, owing to the high usage of these devices in inpatient and outpatient procedures. Hospital procedures include countless surgeries in which a catheter is needed for drug delivery or drainage.  According to the American Nurses Association (ANA), over 560,000 patients acquire CAUTIs annually in hospital settings, highlighting the need for effective stabilization devices to reduce infection risks.

The rising incidence of hospital-acquired infections (HAIs) has fueled demand for innovative catheter stabilization solutions. These minimize complications like CLABSIs and patient safety by preventing dislodged. As a result, there is a growing trend among hospitals towards the adoption of innovative products that possess antimicrobial properties to effectively tackle these challenges. Increased growth in hospital infrastructures in developing regions has fuelled growth in this segment. To meet increasing patient flows and the omnipresence of chronic diseases, governments are pouring huge sums into healthcare facilities. For example, hospitals in the Asia-Pacific region are improving their capabilities with advanced devices and technologies, which, in turn, is increasing the demand for catheter stabilization devices.

Catheter Stabilization Devices Market Regional Insights

In 2023, North America remained the leading region in the catheter stabilization devices market and held a share of nearly 36% of the global market. The dominance of this region can be attributed to several factors such as the high volume of surgical procedures necessitating catheterization, advanced healthcare infrastructure, and high adoption rate of innovative catheter securement solutions. The United States is a key player in this predominance, with the Joint Commission estimating that there are nearly 3 million central venous catheters used each year of the estimated 300 million catheterizations performed in the U.S. The region’s market growth is also supported by favorable government initiatives and stringent healthcare policies to curb catheter-associated infections. The catheter stabilization devices market across Europe is also expected to held a significant share owing to the growing aging population in the region, along with a surge in lifestyle-derived medical conditions such as cardiovascular disorders. Germany, the UK, and France are among the top contributors. Germany is at the forefront of providing advanced manufacturing capabilities for medical devices, and the UK is focused on developing innovative techniques to prevent catheter-related bloodstream infections (CRBSIs). France emphasizes cost-effective solutions in public healthcare settings.

Asia-Pacific emerged as the fastest-growing region with a significant compound annual growth rate (CAGR) during the forecast period. Factors responsible for the growth of the factor are the high healthcare spending, infection prevention awareness levels, and the rising amount of surgical procedures being conducted owing to numerous chronic diseases. The region is dominated by China, with developing healthcare facilities and government initiatives aimed at enhancing patient safety standards. India and Japan also make considerable contributions: India is experiencing a rise in catheterization procedures used in critical care and neonatal applications, while Japan focuses on providing advanced medical technologies accompanied by securement solutions.

Catheter Stabilization Devices Market Key Players

• 3M Company (Tegaderm IV Securement Device, PICC CVC Securement Device)

• B. Braun Melsungen AG (Certofix Securement Device, Introcan Safety)

• Becton, Dickinson and Company (BD) (StatLock Stabilization Device, MaxZero Extension Set)

• Medtronic plc (SecurePortIV Catheter Securement, MiniMed Infusion Sets)

• Smiths Medical (ICU Medical) (CADD Catheter Securement System, Jelco IV Catheters)

• Cardinal Health, Inc. (CVP Securement Device, IV3000 Securement Dressing)

• ConvaTec Group plc (AQUACEL Ag Advantage Securement, DuoDERM Extra Thin Dressing)

• TIDI Products, LLC (Grip-Lok Securement Devices, Sterile Securement Tabs)

• Centurion Medical Products (Medline) (SecurAcath Securement, Sorbaview Shield)

• Mölnlycke Health Care AB (Mepilex Border Post-Op, Mepore Film and Pad)

• DeRoyal Industries, Inc. (CathGrip Securement, DEHP-Free Securement Tape)

• NeoMed, Inc. (NeoSecure Securement Devices, NeoBridge Tube Holder)

• Marpac Inc. (Tracheostomy Tube Holder, ET Tube Holder)

• Halyard Health (Owens & Minor) (MIC-KEY Securement, Halyard Securement Dressings)

• Smith & Nephew plc (IV3000 Film Dressing, Opsite Post-Op Visible)

• Dale Medical Products, Inc. (Stabilock, Hold-n-Place)

• C.R. Bard, Inc. (BD) (StatLock PICC Plus, StatLock Foley Stabilization)

• Marlen Manufacturing & Development Co. (UltraMax Securement, Catheter Strip Securement)

• Interrad Medical, Inc. (SecurAcath Securement System, SecurCath Extended Dwell)

• MedSecure Products (CathSecure Advanced, CathGrip Pro)

Recent Developments in the Catheter Stabilization Devices Market​

• In April 2023, ConvaTec purchased an anti-infective nitric oxide technology platform to expand its portfolio in the area of infection prevention.

• In September 2022, B. Braun Medical Inc. acquired the Clik-FIX catheter securement device product portfolio from Starboard Medical to bolster its peripheral intravenous (IV) therapy business.